Androst-5-ene-3,17 diol is used to treat or reduce the likelihood of acquiring osteoporosis or menopausal symptoms, or other diseases affected by estrogen receptor activity, and for conditions which respond well to DHEA treatment, but where a higher ratio of estrogenic to androgenic effects is desired. Combination therapies are included, as are kits and pharmaceutical compositions or providing the active ingredients of claimed methods and combinations.

 
Web www.patentalert.com

< Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment

< Composition containing 7-hydroxy DHEA and/or 7-keto DHEA and at least a carotenoid

> Method for exfoliating skin

> Process for stabilizing antioxidant compounds, and aqueous compositions

~ 00237